Literature DB >> 27832572

The influence of introducing unrestricted access to sugammadex and quantitative neuromuscular monitors on the incidence of residual neuromuscular block at a tertiary teaching hospital. An audit of 'real-life'.

J I Milne1, C S Ong1, J S Ong2, K C Cheung2, A A Schauer2, S B Buttar2, T Ledowski3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27832572     DOI： 10.1177/0310057X1604400606

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN： 0310-057X            Impact factor:   1.669


× No keyword cloud information.
  3 in total

1.  Use of intraoperative neuromuscular monitor reduces the reversal dose of sugammadex: a single-center retrospective study.

Authors:  Hajime Iwasaki; Atsushi Kurosawa; Takafumi Iida; Tomoki Sasakawa; Hirotsugu Kanda
Journal:  J Anesth       Date:  2020-01-28       Impact factor: 2.078

Review 2.  Preparing for the unexpected: special considerations and complications after sugammadex administration.

Authors:  Hajime Iwasaki; J Ross Renew; Takayuki Kunisawa; Sorin J Brull
Journal:  BMC Anesthesiol       Date:  2017-10-17       Impact factor: 2.217

3.  A multicenter survey on the use of neuromuscular blockade in Greece. Does the real-world clinical practice indicate the necessity of guidelines?

Authors:  Chrysanthi Batistaki; Kyriaki Vagdatli; Adelais Tsiotou; Alexandra Papaioannou; Aggeliki Pandazi; Paraskevi Matsota
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2019 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.